Jeffrey Allen Bailey insider trades

Open-market stock purchases and sales by Jeffrey Allen Bailey, Director at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Aug 30, 2010.

Recent trades

DateStockTradeValue
Jun 4, 2026AUPH Aurinia Pharmaceuticals IncBought (not open market)—
Nov 21, 2025AUPH Aurinia Pharmaceuticals IncSold (not open market)$42.6K

Companies traded

  • AUPH Aurinia Pharmaceuticals Inc: 1 sale, last Jun 4, 2026
  • ALRN Aileron Therapeutics Inc: 3 buys, last Jun 15, 2022
  • BDSI Biodelivery Sciences International Inc: 1 sale, last Mar 22, 2022
  • THW Tekla World HealthCare Fund: 1 buy, last Apr 6, 2021
  • HQH Tekla HealthCare Investors: 1 buy, last Sep 23, 2020
  • THQ Tekla HealthCare Opportunities Fund: 1 buy, last Sep 23, 2020
  • HQL Tekla Life Sciences Investors: 1 buy, last Sep 22, 2020
  • LDR Landauer Inc: other filings, last Oct 19, 2017
  • LNTH Lantheus Holdings, Inc: other filings, last Aug 31, 2015
  • KG King Pharmaceuticals Inc: other filings, last Jan 31, 2011

Get free alerts when Jeffrey Allen Bailey files a new trade →